Skip to main content
Top
Published in: BMC Cancer 1/2024

Open Access 01-12-2024 | Colorectal Cancer | Research

The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer

Authors: Hao Chen, Chao Wang, Zexian Chen, Tianze Huang, Yanyun Lin, Junguo Chen, Bin Zhang, Xiaosheng He

Published in: BMC Cancer | Issue 1/2024

Login to get access

Abstract

Background

Perineural invasion (PNI) is the invasion of nerves by cancer cells and is associated with poor survival in stage II colorectal cancer. However, PNI can be further subdivided according to the depth of invasion, and the depth of PNI has not been clearly linked to prognosis.

Method

This study aimed to assess the prognostic value of different depths of PNI in stage II colorectal cancer. We defined PNI in the submucosal plexus and myenteric plexus as superficial perineural invasion (sup-PNI) and PNI in the subserous plexus as deep perineural invasion (deep-PNI). Patients were divided into three groups based on the depth of PNI: sup-PNI, deep-PNI and non-PNI. Then, univariate and multivariate Cox regression analyses were conducted to evaluate the role of PNI in the prognosis of stage II colorectal cancer.

Results

This study enrolled 3508 patients with stage II colorectal cancer who underwent resection for primary colorectal lesions between January 2013 and September 2019. Clinicopathological features, including elevated carcinoembryonic antigen (CEA) levels, T4 stage, poor differentiation, deficient DNA mismatch repair (dMMR), and vascular invasion, were correlated with deep-PNI. Multivariate analyses revealed that deep-PNI was associated with worse overall survival (OS; hazard ratio [HR], 3.546; 95% confidence interval [CI], 2.307–5.449; P < 0.001) and disease-free survival (DFS; HR, 2.921; 95% CI, 2.032–4.198; P < 0.001), compared with non-PNI. Conversely, no significant difference in OS or DFS was observed between the sup-PNI and non-PNI groups in multivariate analyses.

Conclusions

The study demonstrated that the depth of PNI was an independent prognostic factor for patients with stage II colorectal cancer, and patients with deep PNI had a worse prognosis. Thus, patients with PNI require further subdivision according to the depth of invasion.
Appendix
Available only for authorised users
Literature
1.
go back to reference Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf). 2021;9(2):91–104.CrossRefPubMed Xie Y, Shi L, He X, Luo Y. Gastrointestinal cancers in China, the USA, and Europe. Gastroenterol Rep (Oxf). 2021;9(2):91–104.CrossRefPubMed
4.
go back to reference Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Lieu C, et al. Adjuvant therapy for stage II colon cancer: ASCO guideline update. J Clin Oncol. 2022;40(8):892–910.CrossRefPubMed Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Lieu C, et al. Adjuvant therapy for stage II colon cancer: ASCO guideline update. J Clin Oncol. 2022;40(8):892–910.CrossRefPubMed
5.
go back to reference Cienfuegos JA, Martínez P, Baixauli J, Beorlegui C, Rosenstone S, Sola JJ, Rodríguez J, Hernández-Lizoáin JL. Perineural invasion is a major prognostic and predictive factor of response to adjuvant chemotherapy in stage I-II colon cancer. Ann Surg Oncol. 2017;24(4):1077–84.CrossRefPubMed Cienfuegos JA, Martínez P, Baixauli J, Beorlegui C, Rosenstone S, Sola JJ, Rodríguez J, Hernández-Lizoáin JL. Perineural invasion is a major prognostic and predictive factor of response to adjuvant chemotherapy in stage I-II colon cancer. Ann Surg Oncol. 2017;24(4):1077–84.CrossRefPubMed
6.
go back to reference Skancke M, Arnott SM, Amdur RL, Siegel RS, Obias VJ, Umapathi BA. Lymphovascular invasion and perineural invasion negatively impact overall survival for stage II adenocarcinoma of the colon. Dis Colon Rectum. 2019;62(2):181–8.CrossRefPubMed Skancke M, Arnott SM, Amdur RL, Siegel RS, Obias VJ, Umapathi BA. Lymphovascular invasion and perineural invasion negatively impact overall survival for stage II adenocarcinoma of the colon. Dis Colon Rectum. 2019;62(2):181–8.CrossRefPubMed
7.
go back to reference Kim YI, Kim CW, Kim JH, Kim J, Ro JS, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, et al. Clinical implication of perineural and lymphovascular invasion in rectal cancer patients who underwent surgery after preoperative chemoradiotherapy. Dis Colon Rectum. 2022;65(11):1325–34.CrossRefPubMed Kim YI, Kim CW, Kim JH, Kim J, Ro JS, Lee JL, Yoon YS, Park IJ, Lim SB, Yu CS, et al. Clinical implication of perineural and lymphovascular invasion in rectal cancer patients who underwent surgery after preoperative chemoradiotherapy. Dis Colon Rectum. 2022;65(11):1325–34.CrossRefPubMed
8.
go back to reference Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115(15):3379–91.CrossRefPubMed Liebig C, Ayala G, Wilks JA, Berger DH, Albo D. Perineural invasion in cancer: a review of the literature. Cancer. 2009;115(15):3379–91.CrossRefPubMed
9.
go back to reference Seguella L, Gulbransen BD. Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat Rev Gastroenterol Hepatol. 2021;18(8):571–87.CrossRefPubMedPubMedCentral Seguella L, Gulbransen BD. Enteric glial biology, intercellular signalling and roles in gastrointestinal disease. Nat Rev Gastroenterol Hepatol. 2021;18(8):571–87.CrossRefPubMedPubMedCentral
10.
go back to reference Liebl F, Demir IE, Rosenberg R, Boldis A, Yildiz E, Kujundzic K, Kehl T, Dischl D, Schuster T, Maak M, et al. The severity of neural invasion is associated with shortened survival in colon cancer. Clin Cancer Res. 2013;19(1):50–61.CrossRefPubMed Liebl F, Demir IE, Rosenberg R, Boldis A, Yildiz E, Kujundzic K, Kehl T, Dischl D, Schuster T, Maak M, et al. The severity of neural invasion is associated with shortened survival in colon cancer. Clin Cancer Res. 2013;19(1):50–61.CrossRefPubMed
11.
go back to reference Zhou Y, Wang H, Gong H, Cao M, Zhang G, Wang Y. Clinical significance of perineural invasion in stages II and III colorectal cancer. Pathol Res Pract. 2015;211(11):839–44.CrossRefPubMed Zhou Y, Wang H, Gong H, Cao M, Zhang G, Wang Y. Clinical significance of perineural invasion in stages II and III colorectal cancer. Pathol Res Pract. 2015;211(11):839–44.CrossRefPubMed
12.
go back to reference Cho SS, Park JW, Kang GH, Kim JH, Bae JM, Han SW, Kim TY, Kim MJ, Ryoo SB, Jeong SY, et al. Prognostic impact of extramural lymphatic, vascular, and perineural invasion in stage II colon cancer: a comparison with intramural invasion. Dis Colon Rectum. 2023;66(3):366–73.CrossRefPubMed Cho SS, Park JW, Kang GH, Kim JH, Bae JM, Han SW, Kim TY, Kim MJ, Ryoo SB, Jeong SY, et al. Prognostic impact of extramural lymphatic, vascular, and perineural invasion in stage II colon cancer: a comparison with intramural invasion. Dis Colon Rectum. 2023;66(3):366–73.CrossRefPubMed
13.
go back to reference Ueno H, Shirouzu K, Eishi Y, Yamada K, Kusumi T, Kushima R, Ikegami M, Murata A, Okuno K, Sato T, et al. Characterization of perineural invasion as a component of colorectal cancer staging. Am J Surg Pathol. 2013;37(10):1542–9.CrossRefPubMed Ueno H, Shirouzu K, Eishi Y, Yamada K, Kusumi T, Kushima R, Ikegami M, Murata A, Okuno K, Sato T, et al. Characterization of perineural invasion as a component of colorectal cancer staging. Am J Surg Pathol. 2013;37(10):1542–9.CrossRefPubMed
14.
go back to reference Simillis C, Singh H, Afxentiou T, Mills S, Warren OJ, Smith JJ, Riddle P, Adamina M, Cunningham D, Tekkis PP. Postoperative chemotherapy improves survival in patients with resected high-risk Stage II colorectal cancer: results of a systematic review and meta-analysis. Colorectal Dis. 2020;22(10):1231–44.CrossRefPubMed Simillis C, Singh H, Afxentiou T, Mills S, Warren OJ, Smith JJ, Riddle P, Adamina M, Cunningham D, Tekkis PP. Postoperative chemotherapy improves survival in patients with resected high-risk Stage II colorectal cancer: results of a systematic review and meta-analysis. Colorectal Dis. 2020;22(10):1231–44.CrossRefPubMed
15.
go back to reference NCCN Guidelines: Gradishar WJ, Anderson BO, Balassanian R, et al. NCCN clinical practice guidelines in oncology: colon cancer. Version 2. 2021. Available at: NCCN.org. NCCN Guidelines: Gradishar WJ, Anderson BO, Balassanian R, et al. NCCN clinical practice guidelines in oncology: colon cancer. Version 2. 2021. Available at: NCCN.org.
16.
go back to reference Diagnosis, Treatment Guidelines For Colorectal Cancer Working Group C. Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version). Chin J Cancer Res. 2019;31(1):117–34. Diagnosis, Treatment Guidelines For Colorectal Cancer Working Group C. Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version). Chin J Cancer Res. 2019;31(1):117–34.
17.
go back to reference Zhang B, Lin Y, Wang C, Chen Z, Huang T, Chen H, Wang G, Lan P, He X, He X. Combining perineural invasion with staging improve the prognostic accuracy in colorectal cancer: a retrospective cohort study. BMC Cancer. 2023;23(1):675.CrossRefPubMedPubMedCentral Zhang B, Lin Y, Wang C, Chen Z, Huang T, Chen H, Wang G, Lan P, He X, He X. Combining perineural invasion with staging improve the prognostic accuracy in colorectal cancer: a retrospective cohort study. BMC Cancer. 2023;23(1):675.CrossRefPubMedPubMedCentral
18.
go back to reference Knijn N, Mogk SC, Teerenstra S, Simmer F, Nagtegaal ID. Perineural invasion is a strong prognostic factor in colorectal cancer: a systematic review. Am J Surg Pathol. 2016;40(1):103–12.CrossRefPubMed Knijn N, Mogk SC, Teerenstra S, Simmer F, Nagtegaal ID. Perineural invasion is a strong prognostic factor in colorectal cancer: a systematic review. Am J Surg Pathol. 2016;40(1):103–12.CrossRefPubMed
19.
go back to reference Zhang JF, Tao LY, Yang MW, Xu DP, Jiang SH, Fu XL, Liu DJ, Huo YM, Liu W, Yang JY, et al. CD74 promotes perineural invasion of cancer cells and mediates neuroplasticity via the AKT/EGR-1/GDNF axis in pancreatic ductal adenocarcinoma. Cancer Lett. 2021;508:47–58.CrossRefPubMed Zhang JF, Tao LY, Yang MW, Xu DP, Jiang SH, Fu XL, Liu DJ, Huo YM, Liu W, Yang JY, et al. CD74 promotes perineural invasion of cancer cells and mediates neuroplasticity via the AKT/EGR-1/GDNF axis in pancreatic ductal adenocarcinoma. Cancer Lett. 2021;508:47–58.CrossRefPubMed
20.
go back to reference Lei Y, He X, Huang H, He Y, Lan J, Yang J, Liu W, Zhang T. Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis. Clin Transl Oncol. 2022;24(1):34–47.CrossRefPubMed Lei Y, He X, Huang H, He Y, Lan J, Yang J, Liu W, Zhang T. Nerve growth factor orchestrates NGAL and matrix metalloproteinases activity to promote colorectal cancer metastasis. Clin Transl Oncol. 2022;24(1):34–47.CrossRefPubMed
21.
go back to reference Huang T, Lin Y, Chen J, Hu J, Chen H, Zhang Y, Zhang B, He X. CD51 intracellular domain promotes cancer cell neurotropism through interacting with transcription factor NR4A3 in colorectal cancer. Cancers (Basel). 2023;15(9):2623.CrossRefPubMed Huang T, Lin Y, Chen J, Hu J, Chen H, Zhang Y, Zhang B, He X. CD51 intracellular domain promotes cancer cell neurotropism through interacting with transcription factor NR4A3 in colorectal cancer. Cancers (Basel). 2023;15(9):2623.CrossRefPubMed
22.
go back to reference Liu Q, Ma Z, Cao Q, Zhao H, Guo Y, Liu T, Li J. Perineural invasion-associated biomarkers for tumor development. Biomed Pharmacother. 2022;155:113691.CrossRefPubMed Liu Q, Ma Z, Cao Q, Zhao H, Guo Y, Liu T, Li J. Perineural invasion-associated biomarkers for tumor development. Biomed Pharmacother. 2022;155:113691.CrossRefPubMed
23.
go back to reference Hu G, Li L, Hu K. Clinical implications of perineural invasion in patients with colorectal cancer. Medicine (Baltimore). 2020;99(17):e19860.CrossRefPubMed Hu G, Li L, Hu K. Clinical implications of perineural invasion in patients with colorectal cancer. Medicine (Baltimore). 2020;99(17):e19860.CrossRefPubMed
24.
go back to reference Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22(16):3408–19.CrossRefPubMed Benson AB 3rd, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van Cutsem E, et al. American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol. 2004;22(16):3408–19.CrossRefPubMed
25.
go back to reference Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol. 2004;22(16):3395–407.CrossRefPubMed Figueredo A, Charette ML, Maroun J, Brouwers MC, Zuraw L. Adjuvant therapy for stage II colon cancer: a systematic review from the Cancer Care Ontario Program in evidence-based care’s gastrointestinal cancer disease site group. J Clin Oncol. 2004;22(16):3395–407.CrossRefPubMed
26.
go back to reference Fukuda Y, Tanaka Y, Eto K, Ukai N, Sonobe S, Takahashi H, Ikegami M, Shimoda M. S100-stained perineural invasion is associated with worse prognosis in stage I/II colorectal cancer: its possible association with immunosuppression in the tumor. Pathol Int. 2022;72(2):117–27.CrossRefPubMed Fukuda Y, Tanaka Y, Eto K, Ukai N, Sonobe S, Takahashi H, Ikegami M, Shimoda M. S100-stained perineural invasion is associated with worse prognosis in stage I/II colorectal cancer: its possible association with immunosuppression in the tumor. Pathol Int. 2022;72(2):117–27.CrossRefPubMed
Metadata
Title
The depth of perineural invasion is an independent prognostic factor for stage II colorectal cancer
Authors
Hao Chen
Chao Wang
Zexian Chen
Tianze Huang
Yanyun Lin
Junguo Chen
Bin Zhang
Xiaosheng He
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2024
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-024-12206-9

Other articles of this Issue 1/2024

BMC Cancer 1/2024 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine